Skip to content

Qiagen NV

US · QGEN #1551 by market cap Listed 1970
49.30 -0.33 -0.66%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

✦ Quant Ownership Signal how this is computed

Accumulating
  • The number of reporting institutions increased by 13 in the most recent period (2026/Q3).
  • Total institutional ownership rose 4.9 percentage points.

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Institutional ownership

Held by institutions
86.57% +4.86pp
Institutions
555 +13
As of
2026/Q3 vs. prior period

Holder types

Mutual Fund60.37%
Public Company11.15%
Hedge Fund8.37%
Private Company2.96%
Sovereign Wealth Fund1.82%
Government Pension Fund1.17%
Individual/Insider0.60%
Insurance Company0.43%
VC/PE Fund0.22%
Other12.90%

Top holders as of 2026-11-05

BlackRock 9.98% · 20.60M sh
Amundi Asset Management 4.25% · 8.78M sh
Principal Global Investors, LLC 4.07% · 8.40M sh
UBS Asset Management 3.80% · 7.85M sh
Vanguard Capital Management, LLC 3.03% · 6.26M sh
Barclays PLC 2.93% · 6.04M sh
Morgan Stanley 1.95% · 4.03M sh
JPMorgan Chase & Co. 2.50% · 5.16M sh
MFS Investment Management 2.38% · 4.91M sh
EARNEST Partners, LLC 2.25% · 4.65M sh
Norges Bank Investment Management 1.73% · 3.58M sh
Marshall Wace LLP 1.69% · 3.49M sh
T. Rowe Price Group, Inc. 1.86% · 3.84M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

5 filings tracked · 0 buys · 5 sells

NameRoleStake
Thierry Bernard Former CEO, MD & Member of Management Board 0.21%
Roland Sackers CFO, MD & Member of Management Board 0.19%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2025-08-14 Roland Sackers CFO, MD & Member of Management Board Intent to Sell (Form 144) -29,851 $51.80
2025-08-14 Thierry Bernard Former CEO, MD & Member of Management Board Intent to Sell (Form 144) -23,750 $51.37
2025-08-13 Roland Sackers CFO, MD & Member of Management Board Intent to Sell (Form 144) -17,648 $51.58
2025-08-12 Roland Sackers CFO, MD & Member of Management Board Intent to Sell (Form 144) -47,500 $51.71
2024-09-10 Roland Sackers CFO, MD & Member of Management Board Intent to Sell (Form 144) -23,090 $49.80

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Qiagen NV discussion 0 comments

Add a comment